Aoife Brennan

This profile gathers the share dealings of Aoife Brennan across 3 companies, led by Kyntra Bio, Inc., Synlogic, Inc. and Climb Bio, Inc. We count 16 filings; the first trade dates from 23 September 2019 and the latest from 29 June 2026.

Every open-market trade on record is a sale: 6 sales worth €483k. The rest of the record consists of 8 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 30 June 2026: an open-market sale of €356k, in Climb Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.